Royal Bank of Canada’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-395,300
Closed -$21.3M 7541
2023
Q2
$21.3M Buy
+395,300
New +$21.3M 0.01% 1136
2020
Q2
Sell
-24,300
Closed -$1.06M 6887
2020
Q1
$1.06M Buy
+24,300
New +$1.16M ﹤0.01% 2985
2017
Q1
Sell
-16,500
Closed -$667K 6802
2016
Q4
$667K Buy
+16,500
New +$650K ﹤0.01% 3497

Other funds holding SNY

Royal Bank of Canada's SNY Position: Q1 2026 in Review

Royal Bank of Canada increased its Sanofi (SNY) stake by 18% in Q1 2026, buying an estimated $22M and bringing the position to 3,155,080 shares worth $152M. The position accounts for 0.03% of the portfolio, ranked #492.

Royal Bank of Canada first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q2 2025. 743 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Royal Bank of Canada held 3,155,080 shares of Sanofi worth $152M as of Q1 2026.
  • Royal Bank of Canada bought 470,882 Sanofi shares in Q1 2026, an estimated $22M.
  • Sanofi made up 0.03% of Royal Bank of Canada's portfolio in Q1 2026, its #492 holding.
  • Royal Bank of Canada first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Sanofi position peaked at $156M in Q2 2025.
  • 743 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.